… the efficacy of ivermectin for COVID-19 patients with mild to moderate disease. … COVID-19,
all possible confounders can never be reliably ruled out. However, as the cases of COVID-19 …

… In this article, we examine the efficacy and safety of various vaccines against COVID-19 …
75% efficacy (95% CI, 8.7 to 95.5) in protecting against mild to moderate infection of COVID-19 …

… , it can be especially useful for inpatients or outpatients with mild or moderate illness [11]. …
Some guidelines state that the drug shows viral clearance in patients with mild COVID-19 but …

… The subjects were confirmed COVID-19 patients over 18 years old with cough symptoms,and
the diagnosis is based on Diagnosis and Treatment Protocol for COVID-19 (Trial Version 6)…

… A majority of the patients (97.4%) in the present study had mild COVID-19, which was … had
mild COVID-19. Citation12 This may be attributed to a variation in the definition of COVID-19 …

… pneumonia could produce much better efficacy on patients with COVID-19 infection compared
to treatment with adjuvant medicine alone. Only mild cases were included in this study. …

… The results of the current meta-analysis supported combined CHM-WM could be as potential
candidates in COVID-19 treatment, especially patients with mild and moderate symptoms. …

… that patients with mild COVID-19 treated with favipiravir will … women, diagnosed with mild
COVID-19 within 5 days of … effectiveness of this therapy in treating mild COVID-19 cases. …

… We aimed to evaluate the safety and efficacy of CD24Fc in hospitalised adults with COVID-19
… We aimed to evaluate the safety and efficacy of CD24Fc in hospitalised adults with …

… Studies were excluded if they: (a) were wrong study design or population (ie, patients with
mild to severe or moderate to severe COVID-19 infections); (b) were duplicated research or …